Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)
Clinical trial NCT03031782 · COMPLETED
Trial details
- NCT number
- NCT03031782
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2020-10-07
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.